Xiao-Jian Jia (Xiaojian Jia)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Alcohol Use Disorder

Bipolar Disorder

Magnetic Resonance

Top Venues

Molecular biology reports

SLAS discovery : advancing life sciences R & D

Cerebral cortex (New York, N.Y. : 1991)

Addiction biology

This page only lists publications with an associated author ORCID identifier.

Publications

Javed Iqbal, Geng-Di Huang, Yan-Xue Xue, Mei Yang, Xiao-Jian Jia
Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders. Molecular biology reports 51 (1) (2024)
Javed Iqbal, Geng-Di Huang, Yan-Xue Xue, Mei Yang, Xiao-Jian Jia
Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders. Molecular biology reports 51 (1) (2024)
Javed Iqbal, Maryam Bibi, Geng-Di Huang, Yan-Xue Xue, Jabbar Zaman Khan Khatttak, Mei Yang, Xiao-Jian Jia
Differential regulation of hippocampal transcriptome by circulating estrogen. Functional & integrative genomics 23 (4) (2023)
Fengwei Sun, Jihui Yang, Xiaoying Liu, Gengdi Huang, Zhi Kong, Yu Liu, Yingmei Zhu, Ying Peng, Mei Yang, Xiao-Jian Jia
Characteristics of amplitude of low-frequency fluctuations in the resting-state functional magnetic resonance imaging of alcohol-dependent patients with depression. Cerebral cortex (New York, N.Y. : 1991) (2023)
Mei Yang, Xiao-Jian Jia, Hongying Zhou, Ping Ren, Huan Deng, Zhi Kong, Chunyu Xie, Wenjun Hu, Wentao Jiang, Wentao Lai, Bin Zhang, Min Zhao, Tiebang Liu
Brain dysfunction of methamphetamine-associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit. Addiction biology 26 (6) (2021)
Xiao-Jian Jia, Yu Du, Hua-Jun Jiang, Yong-Zhen Li, Yan-Ni Xu, Shu-Yi Si, Li Wang, Bin Hong
Identification of Novel Compounds Enhancing SR-BI mRNA Stability through High-Throughput Screening. SLAS discovery : advancing life sciences R & D 25 (4) (2019)
Dajun Zhang, Yan Yan, Ge Jin, Bo Liu, Xiaoliang Ma, Dan Han, Xiao-Jian Jia
Synthesis and antitumor evaluation of novel 4-anilino-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate derivatives as potential EGFR inhibitors. Archiv der Pharmazie 351 (9) (2018)